Results for tag: "Necrosis"

Necrosis is a biotechnology market focused on the development of treatments for necrotic tissue, which is tissue that has died due to injury or disease. Necrosis can occur in any part of the body, and can be caused by a variety of factors, including infection, trauma, and radiation. Necrosis can lead to a variety of complications, including infection, pain, and tissue loss. The biotechnology market for necrosis is focused on developing treatments that can reduce the risk of complications and improve the quality of life for those affected. The biotechnology market for necrosis includes a variety of companies, such as BioVentrix, Inc., which develops minimally invasive treatments for heart failure; BioMimetic Therapeutics, Inc., which develops treatments for musculoskeletal conditions; and Osiris Therapeutics, Inc., which develops treatments for tissue repair and regeneration. Other companies in the market include Athersys, Inc., which develops treatments for stroke and other neurological conditions; and Organogenesis, Inc., which develops treatments for wound healing and tissue regeneration. Show Less Read more